Piedmont Investment Advisors’s Idexx Laboratories IDXX Stock Holding History

Piedmont Investment Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-9,066	Closed	-$2.2M	–	331
2020 Q1	$2.2M	Buy	9,066 +1,109	+14%	+$289K	0.09%	193
2019 Q4	$2.08M	Buy	7,957 +352	+5%	+$92.8K	0.07%	209
2019 Q3	$2.07M	Buy	7,605 +109	+1%	+$30.3K	0.08%	201
2019 Q2	$2.06M	Sell	7,496 -137	-2%	-$33.8K	0.08%	205
2019 Q1	$1.71M	Buy	7,633 +144	+2%	+$29.7K	0.07%	227
2018 Q4	$1.39M	Buy	7,489 +405	+6%	+$83K	0.07%	231
2018 Q3	$1.77M	Buy	7,084 +4,825	+214%	+$1.17M	0.07%	222
2018 Q2	$492K	Buy	+2,259	New	+$465K	0.02%	441

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Piedmont Investment Advisors's IDXX Position: Q2 2020 in Review

Piedmont Investment Advisors sold out of Idexx Laboratories (IDXX) in Q2 2020, closing a stake of 9,066 shares — an estimated $2.2M sold.

Piedmont Investment Advisors first reported a position in IDXX in Q2 2018 and held it in 8 quarters. The position peaked at $2.2M in Q1 2020. 802 funds tracked by Wall St. Rank hold IDXX as of Q2 2020.

Piedmont Investment Advisors reported no remaining Idexx Laboratories position as of Q2 2020 after selling out during the quarter.
Piedmont Investment Advisors sold 9,066 Idexx Laboratories shares in Q2 2020, an estimated $2.2M.
Piedmont Investment Advisors first reported a position in Idexx Laboratories in Q2 2018 and held it in 8 quarters.
Piedmont Investment Advisors's Idexx Laboratories position peaked at $2.2M in Q1 2020.
802 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2020.

Based on Piedmont Investment Advisors's 13F filing for Q2 2020.